The 340B Peer-to-Peer Program was created in 2011 by the HRSA Office of Pharmacy Affairs (OPA) and the American Pharmacists Association (APhA) to spotlight high performing 340B entities and recognize them as Leading Practice Sites. Recognized sites provide practical examples of excellence in 340B integrity and quality and serve as a resource for other 340B entities. The program strengthens pre- and post-graduate training of the next generation of pharmacists in 340B, promotes the expansion of clinical pharmacy services in underserved communities, and allows covered entities to share their experiences with the 340B program with APhA, OPA, and other stakeholders.
The main vehicle in which Leading Practice Sites (LPs) communicate their experiences with stakeholders is through the 340B Peer-to-Peer webinar series. Peer-to-Peer webinars are held twice each month on the second and last Wednesdays unless otherwise specified. Peer Mentors from the recognized LPs present on timely topics in an interactive format available to all 340B stakeholders.
All leading practice sites are 340B-covered entities and are selected because of their attention to 340B program compliance and exemplary performance in five areas of practice: access to affordable medications, efficient business practices, outcomes-driven pharmaceutical care, quality assurance, and program integrity.
340B covered entities listed in the 340B database as participating 340B entities are eligible to apply. Eligible entities of all sizes and types are encouraged to apply for the prestigious status as a 340B Peer-to-Peer leading practice site.
Applications are evaluated on the clinical quality and cost-effectiveness of their services in the following areas of practice:
Providing access to affordable medications (using the 340B and Prime Vendor programs), including, but not limited to regulatory and program integrity compliance, compliance with contract pharmacy guidlines (if applicable), and billing practices for payers.
Efficient business operations (attention to basic operational and financial practices), including but not limited to policies and procedures for pharmacy operations, inventory and formulary management, financial management/performance, and contract pharmacy operations and reporting (if applicable).
Quality assurance (Use of technology and infrastructure to achieve superior safety and operations), including but not limited to standards to define pharmacy quality and measures to demonstrate quality improvement and systematic search for knowledge about risks of exposure to drugs and methods to protect individuals from drug exposure.
Outcomes-driven pharmaceutical care (patient-centered medication management practices), including but not limited to implementation of a medication management program, provision of patient-specific education, and monitoring, reporting, and analysis of health outcomes and patient safety measures.
Program Integrity (340B program compliance), including but not limited to maintaining policies and procedures, avoiding duplicate discounts and diversion, and adherence to GPO prohibition guidelines.
340B participating entities selected to become Peer-to-Peer leading practice sites will receive:
$20K stipend for two years of participation
Acknowledgement in publications
American Pharmacists Association membership for three leadership team members
Financial support for select conference attendance to represent 340B stakeholders
A participation plaque